Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05650632 |
|---|---|
| Brief Title: | A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma |
| First Submitted : | December 6, 2022 |
| First Submitted that Met QC Criteria : | December 6, 2022 |
| First Posted : | December 14, 2022 |
| Last Update Submitted that Met QC Criteria : | February 2, 2024 |
| Last Update Posted : | February 6, 2024 |